Increased secreted amyloid precursor protein-α (sAPPα) in severe autism: proposal of a specific, anabolic pathway and putative biomarker
about
Review of targeted treatments in fragile X syndromeA common molecular signature in ASD gene expression: following Root 66 to autismCurrent and future implications of basic and translational research on amyloid-β peptide production and removal pathwaysAutism as early neurodevelopmental disorder: evidence for an sAPPα-mediated anabolic pathwayrSeqDiff: detecting differential isoform expression from RNA-Seq data using hierarchical likelihood ratio test.Rare-variant extensions of the transmission disequilibrium test: application to autism exome sequence data.Cross-disorder comparative analysis of comorbid conditions reveals novel autism candidate genesAbnormal intracellular accumulation and extracellular Aβ deposition in idiopathic and Dup15q11.2-q13 autism spectrum disordersAltered expression of Alzheimer's disease-related genes in the cerebellum of autistic patients: a model for disrupted brain connectome and therapyQuantitative proteomic analyses of cerebrospinal fluid using iTRAQ in a primate model of iron deficiency anemia.Abnormalities in the zinc-metalloprotease-BDNF axis may contribute to megalencephaly and cortical hyperconnectivity in young autism spectrum disorder patients.Impact of acamprosate on plasma amyloid-β precursor protein in youth: a pilot analysis in fragile X syndrome-associated and idiopathic autism spectrum disorder suggests a pharmacodynamic protein marker.Neuronal nucleus and cytoplasm volume deficit in children with autism and volume increase in adolescents and adults.Aberrant T-lymphocyte development and function in mice overexpressing human soluble amyloid precursor protein-α: implications for autism.Altered concentrations of amyloid precursor protein metabolites in the cerebrospinal fluid of patients with bipolar disorderTransgenerational latent early-life associated regulation unites environment and genetics across generationsFinding novel distinctions between the sAPPα-mediated anabolic biochemical pathways in Autism Spectrum Disorder and Fragile X Syndrome plasma and brain tissueImpairment of fragile X mental retardation protein-metabotropic glutamate receptor 5 signaling and its downstream cognates ras-related C3 botulinum toxin substrate 1, amyloid beta A4 precursor protein, striatal-enriched protein tyrosine phosphatase,αT-catenin in restricted brain cell types and its potential connection to autism.GFAP expression and social deficits in transgenic mice overexpressing human sAPPα.Glutamate signaling in benign and malignant disorders: current status, future perspectives, and therapeutic implications.Manduca Contactin Regulates Amyloid Precursor Protein-Dependent Neuronal Migration.Advances in microRNA experimental approaches to study physiological regulation of gene products implicated in CNS disordersThe link between intraneuronal N-truncated amyloid-β peptide and oxidatively modified lipids in idiopathic autism and dup(15q11.2-q13)/autism.What's hAPPening at synapses? The role of amyloid β-protein precursor and β-amyloid in neurological disorders.The human β-amyloid precursor protein: biomolecular and epigenetic aspects.The quest for fragile X biomarkers.Novel roles of amyloid-beta precursor protein metabolites in fragile X syndrome and autism.Restoring Soluble Amyloid Precursor Protein α Functions as a Potential Treatment for Alzheimer's Disease.Brain-Derived Neurotrophic Factor Levels in Autism: A Systematic Review and Meta-Analysis.Neurotrophic Factors in Mouse Models of Autism Spectrum Disorder: Focus on BDNF and IGF-1.Impact of acamprosate on behavior and brain-derived neurotrophic factor: an open-label study in youth with fragile X syndrome.Epigenetic Regulation in Amyloid Precursor Protein with Genomic Rearrangements and the Lesch-Nyhan Syndrome.Aggression in fragile X syndrome.ADAM10 as a therapeutic target for brain diseases: from developmental disorders to Alzheimer's disease.What Have Proteomic Studies Taught Us About Novel Drug Targets in Autism?Meta-Analysis of BDNF Levels in Autism.Altered cytokine and BDNF levels in autism spectrum disorder.The co-occurrence of Down syndrome and autism spectrum disorder: is it because of additional genetic variations?Analysis of peripheral amyloid precursor protein in Angelman Syndrome.
P2860
Q28077180-A132BBFF-8B79-4C6A-BAC2-6511C7BBD04FQ28077428-86B00529-A34C-43EF-A92C-704DC10CB5AAQ28081678-CFD967E9-995D-4AF9-936C-C5ACD1F2C916Q30651711-E37CE14D-5437-4E92-BE64-8A9377359AE5Q30698709-415F8789-B24B-4DAD-8F9F-2F68C6E97EB8Q30721849-2210999E-1B73-4763-8751-56EAD4143307Q33587468-B64428CF-73F2-4109-A45E-25646DD2FD52Q34261556-26D7F139-D491-4BC1-8E53-EBFD1E8965E4Q34421064-C7DDF7FB-CEFB-446B-9855-D0169C00D8E2Q34423339-EE71520B-239E-43FB-880C-8A96E30D8099Q34545273-EA395376-63FC-49ED-9CA2-4B74B8717025Q34620558-9834FE95-19B3-46E1-8148-9F30BDBE5005Q34998124-F97C786A-B5BF-486F-A5BC-87AC6C15BDA7Q35787737-10A14A39-8B47-45F4-A9FA-E8BB560B5BC1Q36610063-BAAC1DCC-B378-4CBC-A00F-82F9FAABEA34Q36893180-A4F76968-974C-4FDF-9AC7-8CA35A6F4975Q36925690-B5378E1D-BBE5-471F-95C2-6A06DABC5F1AQ36985727-8340C689-A099-4578-BCD3-2EBFFBD78539Q37024399-BD45681A-5D9F-4B5D-AAC0-79D5FC7A901BQ37060402-731F786C-4588-478E-B743-1623F8D3603DQ37121338-BD30DCB9-A4DD-4B2E-A8D7-FF12B2D718A5Q37180985-D34BFB99-8CF0-4394-A62A-3FA66E5B5231Q37262741-5BC7D1AE-FE5F-4AA2-93D5-4BDE432AD68CQ37485191-5EC29BEA-AFDB-4E18-81B4-854218A7B753Q38038399-387CC213-BC9B-4080-A7F6-2E9504B7DACBQ38365416-39B0EAEF-3C78-44DF-9DE6-5D33388E1530Q38633043-AE6CBBDE-CA8D-4655-9999-C0D2F50C5762Q38826557-46413076-C76C-4739-993A-5BE30A8D46DBQ38929253-8EAC9AF9-72B1-4DF4-B915-09CCA0787813Q39110745-24E5B99E-0ECD-4B24-8407-38441EC1ADEEQ39334489-C9FD5235-7E4E-4177-AF27-3749F45A01D8Q39462489-9ED62E91-F85A-486B-AE76-347C80AC87B8Q40510522-7547DEC4-D341-4D08-9FF0-FE8F10B35CFAQ41080546-EB3030F4-3708-459C-BBDB-78C5B61DE80AQ47728000-9051C973-714F-450B-856D-285BB9C5CC3EQ47812079-AE0E2CCA-5C9B-4CA0-B8A6-BEE86777A4D7Q48045959-C77BBC3D-7876-45B0-9D97-8A25B9C3E939Q50301293-C40DAA1E-8B49-47EE-9A7A-ED0975324731Q50312020-65277133-783A-449C-9F52-C6D605A5EA4CQ52130370-43297FCC-45F7-461D-8356-9F81C149995D
P2860
Increased secreted amyloid precursor protein-α (sAPPα) in severe autism: proposal of a specific, anabolic pathway and putative biomarker
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Increased secreted amyloid pre ...... pathway and putative biomarker
@ast
Increased secreted amyloid pre ...... pathway and putative biomarker
@en
Increased secreted amyloid pre ...... pathway and putative biomarker
@nl
type
label
Increased secreted amyloid pre ...... pathway and putative biomarker
@ast
Increased secreted amyloid pre ...... pathway and putative biomarker
@en
Increased secreted amyloid pre ...... pathway and putative biomarker
@nl
prefLabel
Increased secreted amyloid pre ...... pathway and putative biomarker
@ast
Increased secreted amyloid pre ...... pathway and putative biomarker
@en
Increased secreted amyloid pre ...... pathway and putative biomarker
@nl
P2093
P2860
P3181
P1433
P1476
Increased secreted amyloid pre ...... pathway and putative biomarker
@en
P2093
Balmiki Ray
Debomoy K Lahiri
Deborah K Sokol
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0020405
P407
P577
2011-06-22T00:00:00Z